Aerogen is the global leader in acute care aerosol drug delivery, pioneering vibrating mesh nebuliser technology used to treat over 30 million patients in more than 80 countries worldwide. Headquartered in Galway, Ireland, Aerogen combines advanced engineering with clinical science to deliver precise, reliable aerosol therapy across hospital settings, from emergency and intensive care to neonatal units.
Founded in 1997, Aerogen is built on a foundation of innovation and research excellence. With more than 300 international patents and extensive clinical validation, the company continues to advance aerosol drug delivery through sustained investment in R&D, improving outcomes for patients in acute care environments worldwide.